X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with VADILAL INDUSTRIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VADILAL INDUSTRIES - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VADILAL INDUSTRIES GSK CONSUMER/
VADILAL INDUSTRIES
 
P/E (TTM) x 38.3 10.5 364.1% View Chart
P/BV x 9.3 2.2 434.7% View Chart
Dividend Yield % 1.0 0.2 405.5%  

Financials

 GSK CONSUMER   VADILAL INDUSTRIES
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
VADILAL INDUSTRIES
Mar-18
GSK CONSUMER/
VADILAL INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs6,7931,174 578.6%   
Low Rs4,919762 645.4%   
Sales per share (Unadj.) Rs1,026.3764.3 134.3%  
Earnings per share (Unadj.) Rs166.521.8 765.3%  
Cash flow per share (Unadj.) Rs181.844.2 411.7%  
Dividends per share (Unadj.) Rs75.001.25 6,000.0%  
Dividend yield (eoy) %1.30.1 991.9%  
Book value per share (Unadj.) Rs828.6243.4 340.4%  
Shares outstanding (eoy) m42.067.20 584.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.71.3 450.5%   
Avg P/E ratio x35.244.5 79.0%  
P/CF ratio (eoy) x32.221.9 146.9%  
Price / Book Value ratio x7.14.0 177.7%  
Dividend payout %45.15.7 784.0%   
Avg Mkt Cap Rs m246,2846,970 3,533.5%   
No. of employees `0004.00.7 589.2%   
Total wages/salary Rs m5,277392 1,346.3%   
Avg. sales/employee Rs Th10,837.38,141.0 133.1%   
Avg. wages/employee Rs Th1,325.0579.9 228.5%   
Avg. net profit/employee Rs Th1,757.7231.7 758.8%   
INCOME DATA
Net Sales Rs m43,1655,503 784.3%  
Other income Rs m2,57434 7,683.9%   
Total revenues Rs m45,7395,537 826.1%   
Gross profit Rs m8,834510 1,731.0%  
Depreciation Rs m644161 399.1%   
Interest Rs m20153 13.3%   
Profit before tax Rs m10,744229 4,683.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,74373 5,140.9%   
Profit after tax Rs m7,001157 4,470.6%  
Gross profit margin %20.59.3 220.7%  
Effective tax rate %34.831.7 109.8%   
Net profit margin %16.22.8 570.0%  
BALANCE SHEET DATA
Current assets Rs m45,6201,628 2,803.1%   
Current liabilities Rs m17,4261,640 1,062.6%   
Net working cap to sales %65.3-0.2 -28,988.6%  
Current ratio x2.61.0 263.8%  
Inventory Days Days3568 51.1%  
Debtors Days Days2428 83.4%  
Net fixed assets Rs m5,1382,640 194.6%   
Share capital Rs m42172 585.0%   
"Free" reserves Rs m34,4311,681 2,048.3%   
Net worth Rs m34,8511,753 1,988.3%   
Long term debt Rs m0710 0.0%   
Total assets Rs m54,1274,401 1,230.0%  
Interest coverage x530.22.5 21,223.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.81.3 63.8%   
Return on assets %13.07.0 184.3%  
Return on equity %20.18.9 224.8%  
Return on capital %30.915.5 198.9%  
Exports to sales %010.0 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA549 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,014549 549.2%   
Fx outflow Rs m186119 156.3%   
Net fx Rs m2,828430 657.6%   
CASH FLOW
From Operations Rs m7,230166 4,355.7%  
From Investments Rs m-4,465-240 1,857.9%  
From Financial Activity Rs m-3,63461 -5,947.6%  
Net Cashflow Rs m-868-13 6,626.7%  

Share Holding

Indian Promoters % 0.0 65.0 -  
Foreign collaborators % 72.5 0.2 48,333.3%  
Indian inst/Mut Fund % 0.8 0.2 381.0%  
FIIs % 12.0 0.0 120,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 34.6 42.8%  
Shareholders   26,457 11,093 238.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   ZYDUS WELLNESS  VENKYS (I) LIMITED  REI AGRO LTD.  RUCHI SOYA INDUSTRIES  HERITAGE FOOD  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Opens Flat; Consumer Durables & Metal Stocks Drag(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 1.4%.

Related Views on News

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VADILAL INDUSTRIES 2017-18 Annual Report Analysis (Annual Result Update)

Sep 20, 2018 | Updated on Sep 20, 2018

Here's an analysis of the annual report of VADILAL INDUSTRIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VADILAL INDUSTRIES. Also includes updates on the valuation of VADILAL INDUSTRIES.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY18); Net Profit Up 20.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 20.4% YoY). Sales on the other hand came in at Rs 12 bn (down 2.4% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VADILAL INDUSTRIES Announces Quarterly Results (4QFY18); Net Profit Down 132.4% (Quarterly Result Update)

Jun 13, 2018 | Updated on Jun 13, 2018

For the quarter ended March 2018, VADILAL INDUSTRIES has posted a net profit of Rs 23 m (down 132.4% YoY). Sales on the other hand came in at Rs 1 bn (up 16.4% YoY). Read on for a complete analysis of VADILAL INDUSTRIES's quarterly results.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Dec 14, 2018 12:41 PM

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS